First Principle Strategies on Behalf of American Laboratories Pharma's latest lobbying report covers Q3 2025, at $37.5K. Its first report covers Q3 2025; the issues it reports most are Health Issues.

First Principle Strategies on Behalf of American Laboratories Pharma

Latest quarter: No record; Q3 2026 · 0 reports
Last 12 months: $0; Last 4 quarters
vs last quarter: No record; Q3 2026 against the quarter before
First report: Q3 2025; The first quarter a report named it

Lobbying by quarter

First Principle Strategies on Behalf of American Laboratories Pharma lobbying by quarter
Quarter	Amount	Reports
Q3 2025	$37.5K	1
Q4 2025	$0	0
Q1 2026	$0	0
Q2 2026	$0	0
Q3 2026	$0	0

By issue

Health issues$37.5K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

HOUSE OF REPRESENTATIVES1 reports
SENATE1 reports

Firms it paid

Firm
Old North Strategies	$37.5K	1 quarters

Former officials lobbying for it

	Former position	Firm
JOSEPH WAYNE KING ii	former Deputy Chief of Staff Congressman Mark Meadows & former Sr. Advisor Congressman Greg Murphy, M.D,	Old North Strategies	Q3 2025

Lobbying reports

	Filed by		Issues
25/11/07for Q3 2025	Old North Strategies	$37.5K	Health issues
25/09/27for Q3 2025	Old North Strategies	Under $5,000	Manufacturing